2008
LONG TERM CLINICAL OUTCOME OF A PHASE I TRIAL OF INTRAVESICAL DOCETAXEL IN THE MANAGEMENT OF SUPERFICIAL BLADDER CANCER REFRACTORY TO STANDARD INTRAVESICAL THERAPY
Laudano M, Murphy A, Petrylak D, Desai M, Benson M, McKiernan J. LONG TERM CLINICAL OUTCOME OF A PHASE I TRIAL OF INTRAVESICAL DOCETAXEL IN THE MANAGEMENT OF SUPERFICIAL BLADDER CANCER REFRACTORY TO STANDARD INTRAVESICAL THERAPY. Journal Of Urology 2008, 179: 121. DOI: 10.1016/s0022-5347(08)60345-6.Peer-Reviewed Original Research
2006
846: Long-Term Follow Up of Intravesical Docetaxel for the Treatment of Superficial Bladder Cancer Resistant to Standard Intravesical Therapy
Masson P, Murphy A, Goetzl M, Desai M, Olsson C, Petrylak D, Benson M, McKiernan J. 846: Long-Term Follow Up of Intravesical Docetaxel for the Treatment of Superficial Bladder Cancer Resistant to Standard Intravesical Therapy. Journal Of Urology 2006, 175: 273. DOI: 10.1016/s0022-5347(18)33082-9.Peer-Reviewed Original Research